Reported 87,120 shares, up 83,931 (2631.9%) from the prior quarter.
Reported value 1669.6%; share count 2631.9% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 56000 |
| 2021-12-31 | 991000 |
| 2022-03-31 | 600000 |
| 2022-06-30 | 643000 |
| 2022-09-30 | 133000 |
| 2022-12-31 | 49949 |
| 2023-03-31 | 227869 |
| 2023-06-30 | 15527 |
| 2023-09-30 | 2840 |
| 2023-12-31 | 3040 |
| 2024-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2024 | Reduced | 0 | -1,000 (-100.0%) | 0 | $0 | 2024-05-15 | |
| Q4 2023 | Unchanged | 1,000 | 0 (0.0%) | < 0.01% | $3,040 | 2024-02-13 | |
| Q3 2023 | Reduced | 1,000 | -4,972 (-83.3%) | < 0.01% | $2,840 | 2023-11-15 | |
| Q2 2023 | Reduced | 5,972 | -119,231 (-95.2%) | < 0.01% | $15,527 | 2023-08-14 | |
| Q1 2023 | Added | 125,203 | +94,931 (313.6%) | < 0.01% | $227,869 | 2023-05-15 | |
| Q4 2022 | Reduced | 30,272 | -39,062 (-56.3%) | < 0.01% | $49,949 | 2023-02-14 | |
| Q3 2022 | Reduced | 69,334 | -145,586 (-67.7%) | < 0.01% | $133,000 | 2022-11-14 | |
| Q2 2022 | Added | 214,920 | +55,570 (34.9%) | < 0.01% | $643,000 | 2022-08-15 | |
| Q1 2022 | Added | 159,350 | +72,230 (82.9%) | < 0.01% | $600,000 | 2022-05-13 | |
| Q4 2021 | Added | 87,120 | +83,931 (2631.9%) | < 0.01% | $991,000 | 2022-02-14 | |
| Q3 2021 | New | 3,189 | +3,189 (0.0%) | < 0.01% | $56,000 | 2021-11-15 |
Who else reported the position
49 managers reported CYTEIR THERAPEUTICS INC for Q4 2021.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Novo Holdings A S | Unchanged | 4,840,413 | 0 | 2.61% | $55,035,000 | 3 qtrs |
| FMR LLC | Reduced | 4,048,993 | -236,666 | < 0.01% | $46,036,000 | 3 qtrs |
| RA CAPITAL MANAGEMENT L P | Unchanged | 3,350,506 | 0 | 0.67% | $38,095,000 | 3 qtrs |
| OUP Management Co LLC | New | 2,474,572 | +2,474,572 | 12.68% | $28,136,000 | 1 qtr |
| Avidity Partners Management LP | Added | 1,849,538 | +166,097 | 0.45% | $21,029,000 | 3 qtrs |
| JANUS HENDERSON GROUP PLC | Reduced | 1,872,421 | -5,803 | < 0.01% | $20,607,000 | 3 qtrs |
| BAKER BROS ADVISORS LP | Unchanged | 812,640 | 0 | 0.04% | $9,240,000 | 3 qtrs |
| BlackRock Inc | Added | 542,422 | +151,023 | < 0.01% | $6,167,000 | 2 qtrs |
| CAAS CAPITAL MANAGEMENT LP | Reduced | 477,510 | -102,236 | 0.13% | $5,429,000 | 3 qtrs |
| ACUTA CAPITAL PARTNERS LLC | Unchanged | 391,974 | 0 | 1.87% | $4,457,000 | 3 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2021
- Filed
- February 14, 2022
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 86,418
- Shared
- 0
- None
- 702
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.